Waldencast PLC (NASDAQ:WALD) Receives Average Rating of “Moderate Buy” from Analysts

Waldencast PLC (NASDAQ:WALD) has received a consensus rating of “Moderate Buy” from the six research firms that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating on the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $4.4167.

Several research firms have weighed in on WALD. Canaccord Genuity Group cut their target price on Waldencast from $5.00 to $4.00 and set a “buy” rating for the company in a research note on Tuesday, November 25th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Waldencast in a research note on Wednesday, January 21st. Jefferies Financial Group started coverage on Waldencast in a report on Wednesday, January 14th. They set a “buy” rating and a $2.00 price target for the company. Finally, Telsey Advisory Group downgraded Waldencast from an “outperform” rating to a “market perform” rating and set a $3.00 price objective for the company. in a research report on Tuesday, November 25th.

Waldencast Stock Down 3.9%

WALD stock opened at $1.46 on Friday. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.53 and a quick ratio of 0.67. Waldencast has a 12 month low of $1.41 and a 12 month high of $3.51. The company’s 50-day moving average price is $1.69 and its two-hundred day moving average price is $1.87.

Waldencast (NASDAQ:WALD) last issued its quarterly earnings results on Monday, November 24th. The company reported ($0.69) earnings per share for the quarter. The firm had revenue of $66.14 million for the quarter. On average, analysts predict that Waldencast will post -0.14 EPS for the current year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in WALD. Milestones Administradora de Recursos Ltda. grew its holdings in shares of Waldencast by 10.3% during the 3rd quarter. Milestones Administradora de Recursos Ltda. now owns 2,425,677 shares of the company’s stock valued at $4,803,000 after purchasing an additional 225,677 shares during the last quarter. Stoic Point Capital Management LLC bought a new position in Waldencast in the 4th quarter valued at approximately $2,628,000. UBS Group AG lifted its stake in Waldencast by 466.2% in the 3rd quarter. UBS Group AG now owns 838,536 shares of the company’s stock valued at $1,660,000 after purchasing an additional 690,441 shares during the last quarter. Geode Capital Management LLC boosted its position in Waldencast by 62.2% in the second quarter. Geode Capital Management LLC now owns 586,566 shares of the company’s stock valued at $1,437,000 after buying an additional 224,905 shares in the last quarter. Finally, Beartown Capital Management LLC bought a new stake in shares of Waldencast during the fourth quarter worth $564,000. Institutional investors own 41.97% of the company’s stock.

Waldencast Company Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. The company also offers clean makeup products under the Milk Makeup brand. It sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners.